Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studiesRachel Sacks‐Davis, Coralie Khan, Joseph Doyle et al.|The Lancet HIV|2024Cited by 24
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)Daniela K van Santen, Ashleigh C. Stewart, Joseph Doyle et al.|International Journal of Epidemiology|2023Cited by 4
Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIVDaniela K van Santen, Sara Lodi, Mathieu Chalouni et al.|Clinical Infectious Diseases|2025Cited by 0